4 Followers on Owler

Bullet Bio

is developing active immunotherapies to stimulate a person’s own immune system to overcome disease... Read more
OverviewCompetitorsFundingNews & Insights

Bullet Bio

is developing active immunotherapies to stimulate a person’s own immune system to overcome disease... Read more
Bullet Bio President & CEO: Willie Quinn

President & CEO

Willie Quinn

CEO Approval Rating

68/100

2011

Private

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
$2.7M

News

Jul 26, 2018
BioPortfolio
Bullet Bio: Bullet Biotechnology Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250
Apr 17, 2018
BioPortfolio
Bullet Bio: Bullet Biotechnology Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27022018 Prices from USD $250
Aug 14, 2017
BioPortfolio
Bullet Bio: Bullet Biotechnology Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 25072017 Prices from USD $250
Mar 29, 2017
BioPortfolio
Bullet Bio: Bullet Biotechnology Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 23032017 Prices from USD $250
Jun 20, 2016
www.sec.gov
Bullet Bio: Received $344K in Debt Funding

Bullet Bio Competitors

1Advaxis
2Selecta
3Agenus
4AnTolRx
5Gritstone Bio
6Kite Pharma
7Moderna
8Inovio
9AstraZeneca
10Apitope
Unlock 31 + competitors

Trending Companies